Manchester Financial Inc Abbott Laboratories Transaction History

Manchester Financial Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	BUY	$102.07 - $123.37 $194,749 - $235,389	1,908 New	1,908 $207,000
Q1 2022 May 04, 2022	SELL	$114.02 - $139.04 $177,187 - $216,068	-1,554 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$115.53 - $141.46 $179,533 - $219,828	1,554 New	1,554 $219,000
Q2 2021 Jul 21, 2021	SELL	$105.79 - $124.53 $170,956 - $201,240	-1,616 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$108.84 - $128.23 $97,956 - $115,406	900 Added 125.7%	1,616 $194,000
Q4 2020 Jan 26, 2021	SELL	$105.0 - $114.42 $1,050 - $1,144	-10 Reduced 1.38%	716 $78,000
Q3 2020 Oct 15, 2020	SELL	$91.64 - $111.29 $1,282 - $1,558	-14 Reduced 1.89%	726 $79,000
Q2 2020 Jul 13, 2020	BUY	$76.57 - $98.0 $3,062 - $3,920	40 Added 5.71%	740 $68,000
Q1 2020 Apr 20, 2020	BUY	$62.82 - $91.86 $6,470 - $9,461	103 Added 17.25%	700 $55,000
Q4 2019 Jan 17, 2020	BUY	$78.51 - $87.4 $46,870 - $52,177	597 New	597 $52,000
Q3 2019 Oct 09, 2019	SELL	$81.84 - $88.74 $29,380 - $31,857	-359 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$72.88 - $85.0 $26,163 - $30,515	359 New	359 $30,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Manchester Financial Inc with notifications on news.